DRKS00014560已完成未知
Analysis and Optimization of the Medication of multimorbid patients on acute geriatric wards - a prospective intervention study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 411
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 70 Years 至 one（—）
- 性别
- All
入选标准
- •Inclusion criteria are the prescription of at least five medications, age of 70 years or above, written informed consent and inpatient stay at Helios Klinikum Schwelm during study time
排除标准
- •- no written informed consent
- •- Patient not able to give an Agreement
- •- life expectancy less than 48 hours
- •- palliative patients with a life expectancy less than one month
- •- communication problems (deaf and dumb/blind)
- •- inclusion in the study in the last three months
研究者
相似试验
已完成
不适用
Pharmacists' review of medicine during admission to hospitalIn-hospital adverse drug eventsOther complications of surgical and medical care, not elsewhere classifiedISRCTN08043800Region Zealand Hospital Pharmacy (Region Sjaelland Sygehusapoteket) (Denmark)648
尚未招募
Unknown
Pharmaceutical guidance for optimizing the use of asthma medicationsAsthmaRBR-9kkjvnjniversidade Federal do Rio Grande do Norte
尚未招募
不适用
Aproach to optimize the dose of contrasut medicum considering patient's blood flow on CTA.JPRN-UMIN000027046Ryukyu unversity hospital50
暂停
不适用
Optimization of the pharmacological component using additive placeboeffects: Is it possible to enhance the psychological component during self-medication by disclosing information about the psychological componentsself-medication: participants using a specific analgesic (ibuprofen, paracetamol, aspirin) for pain relief self-medication: participants using a specific antihistamine (dimetindene, loratadine, cetirizine) for itch reliefDRKS00009506niversitätsklinikum Hamburg-Eppendorf Klinik und Poliklinik für Anästhesiologie108
尚未招募
不适用
Mathematical Modeling-based Medication for Minimizing Malignant evolution of Lung CancerEGFR mutation-positive lung adenocarcinomaJPRN-UMIN000032248Sendai Kosei Hospital5